Profitability
This table compares Acutus Medical and Retractable Technologies’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Acutus Medical | -272.74% | -311.64% | -11.57% |
Retractable Technologies | -41.11% | -17.15% | -9.33% |
Earnings and Valuation
This table compares Acutus Medical and Retractable Technologies”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Acutus Medical | $7.16 million | 0.00 | -$81.66 million | N/A | N/A |
Retractable Technologies | $38.16 million | 0.72 | -$7.01 million | ($0.29) | -3.16 |
Volatility & Risk
Acutus Medical has a beta of -0.67, indicating that its stock price is 167% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500.
Insider & Institutional Ownership
56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 57.1% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Retractable Technologies beats Acutus Medical on 8 of the 9 factors compared between the two stocks.
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
About Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.